Sucralfate
Other Drugs For Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
Sold as Carafate · SULCRATE · SULCRATE SUSPENSION PLUS
- Drug class
- Other Drugs For Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 14
- FDA reports (12 mo)
- 1,168
Overview
Plain-language summary, compiled from the cited regulatory records
Sucralfate is a medication used for the treatment of duodenal ulcers [1]. It belongs to a drug class described as other drugs for peptic ulcer and gastro-esophageal reflux disease (GERD) [1]. Sucralfate is approved for the short-term treatment of active duodenal ulcers, with treatment durations typically up to 8 weeks [1].
This medication is available under various brand names, including Carafate [1]. In the past 12 months, there have been 1168 adverse event reports associated with sucralfate [2]. Common adverse events reported include nausea, diarrhea, fatigue, vomiting, and off-label use [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 10 | March 11, 2026 |
| CA Canada | Health Canada | 4 | May 21, 2026 |
USUnited States· FDA
10 products
Uses
INDICATIONS AND USAGE
Sucralfate Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
How to take
CACanada· Health Canada
4 products
Uses
SULCRATE (sucralfate) Tablets is indicated for: • the treatment of duodenal and non-malignant gastric ulcer. • for the prophylaxis of duodenal ulcer recurrence SULCRATE SUSPENSION PLUS is indicated for: • the treatment of duodenal ulcer and for the prophylaxis of gastrointestinal hemorrhage due to stress ulceration in critically ill patients.
1 Pediatrics (< 18 years of age) No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use. 2 Geriatrics (>65 years of age) No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use.
How to take
Drug interactions
Known interactions involving Sucralfate. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 393. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 0dc592e9-541c-4f… · revised January 28, 2025 [PDF]
- [2]Health Canada (DPD) · 02100622 · revised November 6, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.